Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2012, Article ID 612707, 6 pages
http://dx.doi.org/10.1155/2012/612707
Research Article

The Role of Adjuvant Hormonal Treatment after Surgery for Localized High-Risk Prostate Cancer: Results of a Matched Multiinstitutional Analysis

1Department of Urology and Pediatric Urology, Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Oberdü rrbacher Strasse 6, 97080 Wü rzburg, Germany
2Department of Urology, University Hospitals Leuven, 3000 Leuven, Belgium
3Department of Urology, University of Turin, 10126 Turin, Italy
4Microarray Unit, University of Würzburg, 97078 Würzburg, Germany
5Department of Urology, Vita-Salute San Raffaele University, 20132 Milan, Italy
6College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
7Department of Urology, Université Catholique De Louvain, 1348 Brussels, Belgium
8Department of Urology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany
9Department of Urology, University of Piemonte Orientale, 28100 Novara, Italy
10Department of Urology, Community Hospital Karlsruhe, 76133 Karlsruhe, Germany
11Department of Urology, Erasmus MC, 3015 CE Rotterdam, The Netherlands

Received 15 August 2011; Revised 26 October 2011; Accepted 12 November 2011

Academic Editor: James A. Brown

Copyright © 2012 Maria Schubert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Ramesh Thurairaja, and Anthony Koupparis, “The Role Of Surgery In High-Risk Localised Prostate Cancer,” Bju International, vol. 110, no. 1, pp. E1–E2, 2012. View at Publisher · View at Google Scholar
  • Ramesh Thurairaja, and Anthony Koupparis, “The role of surgery in high-risk localised prostate cancer,” BJU International, vol. 110, no. 1, pp. -E2, 2012. View at Publisher · View at Google Scholar
  • Tanya B. Dorff, and L. Michael Glode, “Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer,” Current Opinion in Urology, vol. 23, no. 4, pp. 366–371, 2013. View at Publisher · View at Google Scholar
  • R. Jeffrey Karnes, Eric J. Bergstralh, Elai Davicioni, Mercedeh Ghadessi, Christine Buerki, Anirban P. Mitra, Anamaria Crisan, Nicholas Erho, Ismael A. Vergara, Lucia L. Lam, Rachel Carlson, Darby J.S. Thompson, Zaid Haddad, Benedikt Zimmermann, Thomas Sierocinski, Timothy J. Triche, Thomas Kollmeyer, Karla V. Ballman, Peter C. Black, George G. Klee, and Robert B. Jenkins, “Validation of a Genomic Classifier That Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population,” The Journal of Urology, 2013. View at Publisher · View at Google Scholar
  • Suzan Stelloo, Ekaterina Nevedomskaya, Henk G. van der Poel, Jeroen de Jong, Geert J.L.H. van Leenders, Guido Jenster, Lodewyk Fa Wessels, Andries M. Bergman, and Wilbert Zwart, “Androgen receptor profiling predicts prostate cancer outcome,” EMBO Molecular Medicine, vol. 7, no. 11, pp. 1450–1464, 2015. View at Publisher · View at Google Scholar
  • Ahmed Larbi, Benjamin Dallaudière, Vasiliki Pasoglou, Anwar Padhani, Nicolas Michoux, Bruno C. Vande Berg, Bertrand Tombal, and Frédéric E. Lecouvet, “Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease,” The Prostate, 2016. View at Publisher · View at Google Scholar
  • Kyong Tae Moon, and Tag Keun Yoo, “Rationale of Surgery in Locally Advanced and Oligometastatic Prostate Cancer,” The Korean Journal of Urological Oncology, vol. 14, no. 3, pp. 97–108, 2016. View at Publisher · View at Google Scholar
  • Stephen E Gilbert, Garry A Tew, Caroline Fairhurst, Liam Bourke, John M Saxton, Edward M Winter, and Derek J Rosario, “Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Qun-Xiong Huang, Zheng Chen, Min-Hua Lu, Chu-Tian Xiao, Jin-Ming Di, Jun Pang, Zi-Huan Luo, and Xin Gao, “Combined analysis of CRMP4 methylation levels and CAPRA-S score predicts metastasis and outcomes in prostate cancer patients,” Asian Journal of Andrology, vol. 20, no. 1, pp. 56–61, 2018. View at Publisher · View at Google Scholar